Acetohydroxamic acid
As of the edition of 20 October 2026, Acetohydroxamic acid is a small molecule: marketed, first approved in 1983 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1984
- Kind
- Small molecule
- Brand name
- Lithostat
- First approved
- 31 May 1983 (US)
- Approvals on record
- 2 in 2 regions
- Holder of the most recent approval
- Ferrer Internacional; 2 holders in all
- Registered trials
- 2, 1 stopped early
- Disease areas
- Infections; Inherited and neonatal; Nervous system; Nutrition and metabolism
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 2 | 2 | 0 | 1 | 1 |
| All trials | 2 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Uro-Research | Earlier holder | 1983 to now |
| Mission Pharmacal | Acquired holder | 2003 to now |